Editor-in- Chief: Luis de Rivera, Madrid, Spain
Associate Editor: Heinrich Wallnöfer , Viena; Austria
Managing Editor: Leonor Monterrey, Madrid, Spain
Pedro Moreno, Mallorca, Spain
Editorial Board:
Roberto Baruzzo, Venice, Italy
Malcolm Carruthers, London, England
Giovanni Gastaldo, Treviso, Italia
Miranda Ottobre Gastaldo, Treviso, Italia
Helen Gibbons, Sydney, Australia
Jose Luis Gonzalez-Mora, Tenerife, Canarias
Carmine Grimaldi, Ancône, Italia
Luis Hernandez-Herrero, Madrid, Spain
Kazuyoshi Koiké, Tokyo, Japan
Marilla Malugani, Padova, Italy
Isabelle Montet, Limoges, France
Juan Carlos Negrete, Montreal, Canada
Philippe Nubukpo, Liege, France
Lucy O’Hagan, Vancouver, Canada
Walter Orrü, Cagliari, Italy
Luciano Palladino, Torino, Italy
Christophe Peugnet, Limoges, France
Herwig Sausgruber, Bregenz, Austria
Friedhelm Stetter, Porta Westfalica, Germany
Frank Suzzoni, Corsica, France
Magda Sz?nyi, Budapest, Hungary
Claudio Widmann, Ravenna, Italia

INFORMATION FOR AUTHORS

The International Journal of Autogenics Research (IJAR) is the official journal of The International Society of Autogenic Training and Psychotherapy, published quarterly by the International Committee for Autogenic Therapy (ICAT). The role of IJAR is to serve as the primal source of information on clinical, basic and applied research in autogenics, ASCI? Therapies and related disciplines, through the publication of papers relevant to social policy, program development, and service delivery. It reflects and informs the broad community of disciplines and professions involved in understanding the psychological, social, physiological and neurobiological effects of autogenics and other concentration methods and its clinical and extraclinical applications, such as in teaching, art and sports. Articles, including those in applied research, should include a conceptual framework and testable hypotheses, and discuss research findings with implications for policy or practice. Brief descriptions of innovative practices and programs are appropriate.

TYPES OF MANUSCRIPTS CONSIDERED FOR PUBLICATION

a. Research Articles present the results of original research. These manuscripts may be no longer than 7,000 words. The word count includes; abstract, text and references. Tables and figures must not exceed an additional 5 pages. The text is usually divided into sections with the headings: Introduction, Design and Methods, Results, and Discussion and Implications. Subheads may also be needed to clarify content. Research design and analysis procedures as well as implications for practice or policy must be clearly described. b. Literature Review and Opinion articles with well-documented arguments presenting a viewpoint on a topical issue . Total length should be no more than 8,000 words. The word count includes the abstract, text and references. c. Brief Reports Brief reports are encouraged for significant and innovative papers that are not as long as full research articles, but are equivalent in quality. Manuscripts should be no more than 2,500 words. The word count includes the abstract, text and references. d. Book Reviews are published in essay form and should be no longer than 2500 words. e. Abstracts and other information from congresses and meetings related to autogenics. f. Informative programs and protocols for clinical or other (i.e., teaching, sports, arts) applications.

FORMATTING

Manuscripts are to be submitted in Microsoft Word times news roman 12 format. Manuscripts submitted in other formats or programas will be returned to the corresponding author for correction prior to editor review. Please DO NOT submit PDF versions of your manuscript submission materials. IJAR papers should use Vancouver style. Ensure that the use of abbreviations is clear and necessary. Each one is defined in the text at its first mention only. A full list of all abbreviations and its definitions shall be submitted as a footnote in the first page of the article.

COMPONENTS OF THE MANUSCRIPT

Title page. A title page should be a completely separate page that includes the following: (1) Title of the manuscript, of no more than 12 words. (2) All authors' full name(s), affiliations, and email addresses. (3) The corresponding author should be clearly designated. Abstract and Keywords. On a separate page, each manuscript must include a brief abstract. Structured abstracts should be approximately 300 words- Below the abstract, authors should supply three to five key words that are NOT in the title. All the words in the title are available to the search engines, so, use others. Acknowledgment (Optional). If the authors choose to include acknowledgments recognizing funders or other individuals, they should be placed on a separate page immediately following the title page. Conflict of Interest At the point of submission, each author should reveal any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated - including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition. When considering whether you should declare a conflicting interest or connection please consider the conflict of interest test: Is there any arrangement that would embarrass you or any of your co-authors if it was to emerge after publication and you had not declared it?

FUNDING

Details of all funding sources for the work in question should be given.

• The sentence should begin: This work was supported by
• The full official funding agency name should be given, i.e. National Institutes of Health, not NIH . Grant numbers should be given in brackets as follows: [grant number xxxx]
• Multiple grant numbers should be separated by a comma as follows: [grant numbers xxxx, yyyy]
• Agencies should be separated by a semi-colon (plus and before the last funding agency)

Tables

Tables are to be numbered consecutively with Arabic numbers and have a brief title for each. Place table footnotes immediately below the table, using superscript letters (a, b, c) as reference marks. Asterisks are used only for probability levels of tests of significance (*p<.05). Tables should be placed at the end of the anonymous and non-anonymous manuscripts, following the references.

Figures/Illustrations

Please include your figures at the end. Each figure should be at sufficient resolution (i.e., 300 dpi at 5 in.) to be clear, sharp images when reduced to print size. Figures must be professionally lettered in a sans-serif type (e.g., Arial or Helvetica). All labels used in figures should be in upper case in both the figure and the caption.

Captions for Tables and Illustrations

Type table titles and figure captions on a separate page following the references in the main document with numbers corresponding to the tables and illustrations. Table titles and figure captions should provide sufficient information so that the reader can understand the tables and figures with minimal reference to the text. Explain symbols, arrows, numbers, or letters used in illustrations. Explain internal scale and identify staining method in photomicrographs.

Supplementary Material

Supplementary material can be made available by the publisher onlineand linked to the published article. This material includes supporting material that is not essential for inclusion in the full text to understand the conclusions of the paper but contains data that is additional or complementary and directly relevant to the article content and therefore may benefit the reader. Such information might include more detailed methods, extended data sets/data analysis, or additional figures.

ADDITIONAL POLICIES AND CONSIDERATIONS

Permissions for Illustrations and Figures

Permission to reproduce copyright material, for print and online publication in perpetuity, must be cleared and if necessary paid for by the author; this includes applications and payments to DACS, ARS and similar licensing agencies where appropriate. Evidence in writing that such permissions have been secured from the rights-holder must be made available to the editors; submit this evidence by uploading the letter as a "Permission for Previously Published Material" file in the File Upload section of the journal submission site. It is also the author's responsibility to include acknowledgments as stipulated by the particular institutions. Oxford Journals can offer information and documentation to assist authors in securing print and online permissions: please see Sections 2.3 and 2.6 when you click on Guidelines for Author Permissions in "Rights and Permissions Guidelines for Authors" at http://www.oxfordjournals.org/access_purchase/rights_permissions.html. Information on permissions contacts for a number of main galleries and museums can also be provided. If you require copies of the Permissions Guidelines for Authors, please contact the editorial office of the journal in question or the Oxford Journals Rights department.

ETHICS

IJAR expects that authors will observe high standards with respect to publication ethics. For example, the following practices are unacceptable: (1) falsification or fabrication of data, (2) plagiarism, including duplicate publication of the authors' own work, in whole or in part without proper citation, (3) misappropriation of the work of others such as omission of qualified authors or of information regarding financial support. Allegations of unethical conduct will be discussed initially with the corresponding author. In the event of continued dispute, the matter will be referred to the author's institution and funding agencies for investigation and adjudication. Any study using human subjects or materials needs to state the Institutional Review Board approval and number, and any study using animals needs to state the Institutional Animal Care approval and number. Any other ethics approvals should also be listed. If no ethical approvals were required, please state this.

Statement of Informed Consent

Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify individuals who provide writing assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. If complete anonymity is difficult to achieve, informed consent should be obtained if there is any doubt.

Conditions for submission

Submission of a manuscript to IJAR implies that it has not been published or is not under consideration elsewhere. If accepted for this journal, it is not to be published elsewhere without permission. As a further condition of publication, the corresponding author will be responsible, where appropriate, for certifying that permission has been received to use copyrighted instruments or software employed in the research and that human or animal subjects approval has been obtained. In the case of coauthored manuscripts, the corresponding author will also be responsible on behalf of his or her co-authors indicating that the manuscript is original work has not been previously published, will not be submitted for publication to any other journal following acceptance in IJAR, and all necessary permissions have been received.

REVIEW PROCESS

All papers published in IJAR are subject to peer review. Papers that are outside the scope of the journal, that do not comply with the guidelines or are otherwise judged to be unsuitable by the editor will be rejected without peer review. Peer-reviewed manuscripts are sent to at least two independent referees for evaluation. Authors are encouraged to suggest reviewers of international standing. Reviewers advise on the originality and scientific merit of the paper; the editors make all final decisions on publication. The corresponding author will be notified via email with a decision and revision requirements, if applicable. Please ensure that email addresses are current for notification purposes.

PAPER ACCEPTANCE INFORMATION

Licenses and Copyright

It is a condition of publication in IJAR that authors grant an exclusive license to ICAT. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. Upon receipt of accepted papers at IJAR, authors will release a copyright license to ICAT. As part of the license agreement, authors may use their own material in other publications provided that IJAR is acknowledged as the original place of publication and ICAT as the Publisher. Please note that by submitting a manuscript for consideration for publication, you confirm that you are the corresponding/submitting author and that IJAT may retain your email address for the purpose of communicating with you about the submission. You agree to notify IJAR immediately if your details change. If your article is accepted for publication IJAP will contact you using the email address you designated in the submission process. Please note that IJAP does not retain copies of rejected articles.